After a Setback, What’s Next for Deciphera Pharmaceuticals?
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a commercial-stage biopharmaceutical focused on creating novel therapies for treatment of cancer, announced that a crucial phase 3...
Coverage
- All
- Beauty
- Biotechnology
- Cannabis
- Communications
- Education
- Energy
- Entertainment
- Environment
- ETFs
- Finance
- Fitness
- Food and Beverage
- Healthcare
- Hospitality
- Insider Trading
- Investing Ideas
- Macro
- Market Insight
- Miscellaneous
- Power
- Real Estate
- Retail
- Sectors
- Security
- Startups
- Technologies
- Trending
- Uncategorized
Can eMAGIN Capitalize on the Burgeoning AR/VR Opportunities?
eMAGIN corporation, (NYSEMKT: EMAN), a leading designer and manufacturer of OLED microdisplays for high-resolution AR/VR and other near-eye imaging products announced a new...
4 Small-Cap Biotech Stocks for Your Investment Portfolio!
Clinical-Stage companies offer an exciting investment opportunity with massive upside potential. Most of these companies bring new and highly differentiated approaches, advanced scientific...
Zix Corporation : An Attractive Small Cap Growth Stock!
Zix Corporation, (NASDAQ: ZIXI), formerly known as ZixIt Corporation, is a premier cloud and email security company that offers a seamless experience to...
Should BeyondSpring be a part of your Portfolio?
BeyondSpring, Inc. (NASDAQ: BYSI) is a clinical-stage biopharmaceutical company focused on creating transformative treatments for immune-oncology conditions. The Company’s lead candidate is plinabulin,...
4 Growth Stocks to Consider for Your Investment Portfolio!
Technology Industry has been focused on leaving the COVID-19 pandemic behind, and marching ahead with its innovations and breakthroughs, be it critical security...
4 Small-Cap Stocks Insiders are Selling!
Insider selling cannot be the sole indicator for investing in a stock, but it would be wise to make a note of the...
Oyster Point Pharma Hits the Bulls EYE!
Oyster Point Pharma, Inc. (NASDAQ: OYST) is a commercial-stage biopharmaceutical company creating first-in-class therapies for the treatment of ophthalmic conditions. The Company’s lead...
All you need to know about NRx Pharmaceuticals!
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) is a clinical-stage biopharmaceutical company focused on creating novel therapeutics that use molecules to treat medical conditions with...
